SCIENTIFIC PROGRAM

Saturday, October 17, 2015

08:40-09:20
Room 101
Plenary Lecture 6
Co-organized by Taiwan Association for the Study of the Liver
Moderator: Ding-Shinn Chen (Taiwan)

PL 6
Current Antiviral Therapy in Patients with Chronic HBV Infection
Yun-Fan Liaw (Taiwan)

09:20-10:00
Room 101
Plenary Lecture 7
Co-organized by Taiwan Association for the Study of the Liver
Moderator: Juergen Rockstroh (Germany)

PL 7
Interferon-free Therapy for Chronic Hepatitis C
Edward J Gane (New Zealand)

10:30-12:00
Room 101
Symposium 7
Co-organized by Taiwan Association for the Study of the Liver
Hepatitis B Virus
Moderators: Rong-Nan Chien (Taiwan); Ming-Lung Yu (Taiwan)

SP 7-1
New Targets for Antiviral Therapies against Hepatitis B Virus
Pei-Jer Chen (Taiwan)

SP 7-2
Interferon-based Therapy for Chronic Hepatitis B
Chun-Jen Liu (Taiwan)

SP 7-3
Nucleos(t)ide Analogue-based Therapy for CHB
Vincent Wai-Sun Wong (China)

SP 7-4
Long-term Outcome of CHB Treatment
Tetsuya Hosaka (Japan)

10:30-12:00
Room 102
Symposium 8
Co-organized by USA CDC & Rota Council
Viral Gastroenteritis
Moderators: Tony Nelson (Hong Kong); Kung-Chia Young (Taiwan)

SP 8-1
Norovirus in the United States
Aron J. Hall (USA)

SP 8-2
Norovirus Outbreak and Surveillance in Taiwan
Fang-Tzy Wu (Taiwan)

OS 8-3
Emergence and Predominance of a Fast-mutating and Putatively Immune-escaped Novel Variant of Norovirus Genogroup II Genotype 17 in Hospitalized Gastroenteritis, 2014—2015, Hong Kong
Martin Chi-Wai Chan (Hong Kong)

OS 8-4
Molecular Surveillance of Acute Gastroenteritis Pathogens in Kuala Lumpur, Malaysia
Chee Sian Kuan (Malaysia)

OS 8-5
Evolutionary Dynamics of Norovirus Infection in Immunocompromised Hosts
John-Sebastian Eden (Australia)

10:30-12:00
Room 103
Symposium 9
HIV Antiretroviral Therapy
Moderators: Josep M Llibre (Spain); Wang-Huei Sheng (Taiwan)

SP 9-1
Therapeutic Application of Antiviral Resistance Testing
Carlo F. Perno (Italy)

SP 9-2
Antiretroviral Therapy for Patients Co-infected with Viral Hepatitis
Jürgen Rockstroh (Germany)

SP 9-3
Optimization of Combination Antiretroviral Therapy in Asia-Pacific Region
Chien-Ching Hung (Taiwan)

10:30-12:00
Room 105
Oral Session 3
Viral Epidemiology
Moderators: Cécile Viboud (USA); Jen-Ren Wang (Taiwan)

OS 3-1
NCBI Bioinformatics Resources for Influenza and Other Emerging Infectious Viruses
Yiming Bao (USA)

OS 3-2
A Tentative Global Map of Hemispheric Influenza Vaccine Recommendations Based on Seasonality
Wladimir Jimenez Alonso (USA)

OS 3-3
Increasing Similarity in the Dynamics of Influenza in Two Adjacent Subtropical Chinese Cities Following the Relaxation of Border Restrictions
Yi Tan (USA)

OS 3-4
Static and Dynamic Factors for Predicting H7N9 Epidemics in China
Haogao Gu (China)

OS 3-5
Clinical and Epidemiological Characteristics of Human Parainfluenza Virus Infection of Children in Southern Taiwan during 2012-2014
Kai Wen Wu (Taiwan)

OS 3-6
Epidemiological Analysis on Breakthrough Cases of Varicella Outbreaks in District of Minhang, Shanghai
Yan-Feng Zhu (China)

OS 3-7
Association between CD4 Count Baseline and Immunological Failure among Care Support and Treatment (CST) Clients in Yayasan Kerthi Praja, Bali
Ni Putu Ayu Astri Prana Iswara (Indonesia)

OS 3-8
Human Herpesvirus Type 8 in Tuberculosis Patients with Effusion
Cheng-Chuan Su (Taiwan)

OS 3-9
Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B with New Onset Hypertension
Yi-Wen Huang (Taiwan)

OS 3-10
Prevalence of HIV/AIDS Immunological Failure among Sex Workers in Yayasan Kerthi Praja, Bali
Hilda Citrajaya (Indonesia)

13:30-15:00
Room 101
Symposium 10
Co-organized by Taiwan Association for the Study of the Liver
Hepatitis C Virus
Moderators: Tetsuya Hosaka (Japan); Pei-Jer Chen (Taiwan)

SP 10-1
All Oral Direct Acting Antiviral Therapy for Chronic Hepatitis C
Kazuaki Chayama (Japan)

SP 10-2
Chronic Hepatitis C: From Bench to Practice
Keng-Hsin Lan (Taiwan)

SP 10-3
Overview of Directly Acting Antiviral Agents for HCV
Ming-Lung Yu (Taiwan)

SP 10-4
Interferon-based Therapy for Chronic Hepatitis C
Sang Hoon Ahn (Korea)

13:30-15:00
Room 102
Symposium 11
Co-organized by USA CDC & Rota Council
Viral Gastroenteritis
Moderators: Aron J. Hall (USA); Ho-Sheng Wu (Taiwan)

SP 11-1
Rotavirus Surveillance and Vaccine Introduction Experience in the US
Catherine Yen (USA)

SP 11-2
Challenges to Introducing Rotavirus Vaccines in Asia
Tony Nelson (Hong Kong)

SP 11-3
Rotavirus Vaccine Introduction in NIP: The Philippine Experience
Lulu Bravo (Philippines)

SP 11-4
Rotavirus Vaccines in Taiwan: Effectiveness, Fecal Viral Shedding and Cost-effectiveness
Yhu-Chering Huang (Taiwan)

13:30-15:00
Room 103
Symposium 12
HIV Epidemiology
Moderators: Carlo F. Perno (Italy); Yen-Fang Huang (Taiwan)

SP 12-1
Updates on the Resistance Profile of Integrase Inhibitors and Their Clinical Application in Treatment Failure and Treatment-naïve Patients
Josep M Llibre (Spain)

SP 12-2
China Free ART Outcomes and Challenges
Fujie Zhang (China)

OS 12-3
Surveillance of HIV Recent Infection and Transmitted Drug Resistance of HIV-1 Strains from Newly-diagnosed, Treatment-naïve Persons in a Singaporean Cohort
Carmen Low (Singapore)

OS 12-4
Potential Drug-drug Interactions between Antiretrovirals and Medications for Comorbidities among the Aging HIV-infected Patients
Jia-An Hung (Taiwan)

OS 12-5
HIV Pre-exposure Prophylaxis: PK-PD Studies on Anti-HIV Drugs Maraviroc, Raltegravir and Tenofovir in a Humanized Mouse Model
Ramesh Akkina (USA)

13:30-15:00
Room 105
Oral Session 4
Arbovirus
Moderators: Ching-Len Liao (Taiwan); Chuan-Liang Kao (Taiwan)

OS 4-1
Minimizing the Global Threat of Dengue Haemorrhagic Fever: Implications from Taiwan's Surveillance, Epidemiological Findings and Public Health Policies
Chwan-Chuen King (Taiwan)

OS 4-2
The Involvement of TLR6 in Immunopathogenesis of Dengue Virus Infection
Justin Jang Hann Chu (Singapore)

OS 4-3
Use of Recombinant Adenovirus Vectored Mouse IFN-α (mDEF201) to Mitigate Chikungunya Virus Infection in BALB/C Mouse Model
Huixin Chen (Singapore)

OS 4-4
Dengue Virus and Antiplatelet Autoantibodies Synergistically Induce Hemorrhage in the Two-hit Mouse Model
Hsin-Hou Chang (Taiwan)

OS 4-5
High-mobility Group Box 1 Protein and Its Role in Acute Dengue Infection
Tzong-Shiann Ho (Taiwan)

OS 4-6
A New Rapid Diagnostic Test for Acute Dengue Infection
Tzong-Shiann Ho (Taiwan)

OS 4-7
Development and Evaluation of a SYBR Green-based Multiplex Reverse Transcriptase-polymerase Chain Reaction for Rapid Diagnosis and Serotyping of Dengue and Chikungunya Viruses
Huixin Chen (Singapore)

OS 4-8
Differential Detection of Antibodies Specific to Bat Coronavirus in the Bat Biologists in Taiwan
Yi-Ning Chen (Taiwan)

OS 4-9
SARS Coronavirus Papain-like Protease Induces Egr-1-mediated Up-Regulation of TGF-β1 in Pro-fibrotic Responses
Cheng-WenLin (Taiwan)

OS 4-10
Hand-held Point-of-care Test Device for the Rapid Detection of Viral Infections
James Mahony (Canada)

15:30-16:10
Room 101
Plenary Lecture 8
Moderator: Wu-Tse Liu (Taiwan)

PL 8
KSHV and Viral Epigenomics
Hsing-Jien Kung (Taiwan)

16:10-16:50
Room 101
Plenary Lecture 9
Moderator: Tzu-Ming Pan (Taiwan)

PL 9
Coronavirus Diversity, Phylogeny and Interspecies Jumping
Patrick CY Woo (Hong Kong)

17:00-18:30
Room 105
Oral Session 5
Enterovirus
Moderators: Luan-Yin Chang (Taiwan); Robert YL Wang (Taiwan)

OS 5-1
Haplotype Preference of Enterovirus 71 in Human Central Nerve System
Sheng-Wen Huang (Taiwan)

OS 5-2
Epidemiological Surveillance of Hand, Foot and Mouth Disease in Shanghai, 2010-2014
Yanling Ge (China)

OS 5-3
Molecular Characterization and Genotyping of Human Adenovirus in Hospitalized Children with Sporadic Gastroenteritis in Shanghai, China, 2006-2011
Lijuan Lu (China)

OS 5-4
Age-specific Incidence Rates of Enterovirus 71 Infections in Young Children in Taiwan, 2008–13
Shu-Ting Luo (Taiwan)

OS 5-5
UDP-glucose Glycoprotein Glucosytransferase 1 Deploys from Endoplasmic Reticulum to Cytosol and Associates with Enterovirus 71 3D Polymerase to Facilitate Viral RNA Elongation Activity
Peng-Nien Huang (Taiwan)

OS 5-6
Enterovirus A71 Triggers Autophagosome-lysosome Fusion to Facilitate Viral Replication
Yoke Fun Chan (Malaysia)

OS 5-7
Surveillance and Comparison of Human Astrovirus Circulation in Hospitalized Children and Outpatients with Acute Diarrhea in Shanghai
Lijuan Lu (China)

OS 5-8
Genotype-specific Effects of HCV Frame-shift (F) Protein in Interferon Induction and Response Pathways
Yi-Ting Lai (Taiwan)

OS 5-9
Activation of Hepatitis B Virus Transcription by CRTC1 Coactivator and PRMT5 Protein Arginine Methyltransferase
Dong-Yan Jin (Hong Kong)

OS 5-10
Characterization of Liver Pathogenesis and Human Immune Responses in a Humanized Mouse Model of Hepatitis C Virus Infection
Yee-Joo Tan (Singapore)